leisure time -WSS

leisure time

author：Wikipedia 2025-08-11 09:49:06 - browse：95665

An effective treatment for Alzheimer’s disease has long been a holy grail in the pharmaceutical industry. In early June, some hope appeared when the FDA agreed that the anti-amyloid antibody lecanemab (to be sold by Eisai as Leqembi) outperformed placebo in trials. It is expected to receive full approval by July 6.

But this may not necessarily be purely good news.

On the latest episode of the “First Opinion Podcast,” physician and professor Jason Karlawish argues that lecanemab and other promising new drugs, such as donanemab, will introduce complicated issues into the field of Alzheimer’s care. These medications require a great deal of testing and patient monitoring, trained physicians, and other resources in a system that is already stretched thin.

“Dr. Karlawish’s dream of reason would be … a training module for physicians to learn the key things they need to learn and then self-assess their comfort with the drug,” Karlawish said. “But that’s Karlawish’s dream of reason in a world that seems increasingly less reasonable sometimes.”

Karlawish is a professor of medicine, medical ethics and health policy, and neurology at the University of Pennsylvania’s Perelman School of Medicine. The conversation is based off his recent First Opinion, “The FDA needs a risk evaluation and mitigation strategy for Alzheimer’s drug lecanemab.“

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Pharma needs to include young adults in clinical research

Wikipedia

WSS

Decentralized clinical trials need collaboration to achieve wider use

Stroke rates rising, especially in working

Should insurance cover cosmetic surgery?

Beyond aggravation: Constipation is an American epidemic

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

entertainment

leisure time

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

Lawsuit challenges CMS nursing home minimum staffing rule

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Unmasking the 'centricity' illusion in clinical trials

Tori Bowie and the unacceptable rates of Black maternal death

J&J reports mixed data on next

Continuity nursing helped my family in our darkest PICU moments

Louisiana bill approved classifying abortion pills as controlled substances

Duchenne breakthrough therapy leaves behind pioneering families

Pharma needs to include young adults in clinical research

Wikipedia

Slain Parkland victim's father speaks out following reenactment

Rock icon Freddie Mercury pre

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Clinicians often fail to acknowledge the pain caused by long Covid

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Climate activists disrupt London Pride march to protest corporate sponsorship

entertainment

hotspot

Wikipedia

hotspot